Patrick Gallagher, CFA

Prior, Pat cofounded and served as CEO of PD Theranostics (PDTx). PDTx merged with Ovation.io in September of 2024 to create a global leader in multiomic data generation, licensing, and translational/foundational LLM development. He is a Director of Ovation and oversees the PDTx platform integration and development.
He has 30 years of direct capital markets experience (research, research sales, investment banking) in both private and public markets analyzing and investing in new technologies and business models within the life sciences and healthcare industry.